Publisher
Springer International Publishing
Reference54 articles.
1. Abdolhosseinzadeh S, Sina M, Ahmadiani A, Asadi S, Shams J (2019) Genetic and pharmacogenetic study of glutamate transporter (SLC1A1) in Iranian patients with obsessive-compulsive disorder. J Clin Pharm Ther 44(1):39–48
2. Ahmadipour E, Rashidi FS, Ahmadiani A, Asadi S, Shams J (2018) SLC6A4 polymorphisms rs25533 and I425V: association with obsessive-compulsive disorder and its treatment response in Iranian patients. Personalized Med Psychiatry 11-12:23–29
3. Altar CA, Hornberger J, Shewade A, Cruz V, Garrison J, Mrazek D (2013) Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy. Int Rev Psychiatry 25(5):509–533
4. American Psychiatric Association (APA) (2007) Practice guideline for the treatment of patients with obsessive-compulsive disorder. Arlington, VA, USA. http://www.psych.org/psych_pract/treatg/pg/prac_guide.cfm
5. Bernard S, Neville KA, Nguyen AT, Flockhart DA (2006) Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications. Oncologist 11(2):126–135
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献